Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, Szaserow 128 Street, Warsaw, Poland.
Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, Szaserow 128 Street, Warsaw, Poland; Postgraduate School of Molecular Medicine, Zwirki i Wigury 61 Street, Warsaw, Poland.
Semin Cancer Biol. 2022 Jun;81:24-36. doi: 10.1016/j.semcancer.2021.03.003. Epub 2021 Mar 13.
Ploidy increase has been shown to occur in different type of tumors and participate in tumor initiation and resistance to the treatment. Polyploid giant cancer cells (PGCCs) are cells with multiple nuclei or a single giant nucleus containing multiple complete sets of chromosomes. The mechanism leading to formation of PGCCs may depend on: endoreplication, mitotic slippage, cytokinesis failure, cell fusion or cell cannibalism. Polyploidy formation might be triggered in response to various genotoxic stresses including: chemotherapeutics, radiation, hypoxia, oxidative stress or environmental factors like: air pollution, UV light or hyperthermia. A fundamental feature of polyploid cancer cells is the generation of progeny during the reversal of the polyploid state (depolyploidization) that may show high aggressiveness resulting in the formation of resistant disease and tumor recurrence. Therefore, we propose that modern anti-cancer therapies should be designed taking under consideration polyploidization/ depolyploidization processes, which confer the polyploidization a hidden potential similar to a Trojan horse delayed aggressiveness. Various mechanisms and stress factors leading to polyploidy formation in cancer cells are discussed in this review.
倍性增加已在不同类型的肿瘤中被发现,并参与肿瘤的发生和对治疗的抵抗。多倍体巨癌细胞(PGCCs)是指具有多个核或单个巨大核的细胞,其中包含多个完整的染色体组。导致 PGCCs 形成的机制可能取决于:内复制、有丝分裂滑步、胞质分裂失败、细胞融合或细胞自噬。多倍体的形成可能是对各种遗传毒性应激的反应,包括:化疗药物、辐射、缺氧、氧化应激或环境因素,如:空气污染、紫外线或高温。多倍体癌细胞的一个基本特征是在多倍体状态的逆转(去倍性)过程中产生后代,这可能表现出高度侵袭性,导致耐药性疾病和肿瘤复发的形成。因此,我们提出,现代抗癌疗法的设计应考虑多倍体化/去倍性化过程,这赋予了多倍体化一种类似于潜伏性延迟侵袭性的特洛伊木马的潜在隐藏性。本文综述了导致癌细胞多倍体形成的各种机制和应激因素。